Claims
- 1. An oxonol compound represented by the following formula (I): ##STR65## in which Z is an atomic group that forms a cyclic amide ring; each of W.sup.1 and W.sup.2 independently is an atomic group that forms an acidic nucleus ring; and M is a cation.
- 2. The oxonol compound as claimed in claim 1, wherein each of W.sup.1 and W.sup.2 independently is an atomic group that forms a pyrazolone ring.
- 3. The oxonol compound as claimed in claim 1, wherein Z is an atomic group that forms a five or six-membered heterocyclic ring.
- 4. The oxonol compound as claimed in claim 1, wherein the oxonol compound is represented by the following formula (Ia): ##STR66## in which each of Z.sup.a, W.sup.1a and W.sup.2a independently is an atomic group that forms a heterocyclic ring; and M.sup.a is a cation.
- 5. The oxonol compound as claimed in claim 1, wherein the oxonol compound is represented by the following formula (Ib): ##STR67## in which X.sup.b is --CHR.sup.1b --, --CR.sup.2b .dbd., --NR.sup.3b -- or --N.dbd., wherein R.sup.1b is hydrogen, hydroxyl or carboxyl, R.sup.2b is hydrogen or is combined with R.sup.8b to form a benzene ring condensed with the cyclic amide ring, and R.sup.3b is hydrogen or an alkyl group having 1 to 20 carbon atoms; Y.sup.b is --CR.sup.4b R.sup.5b --, --CR.sup.6b .dbd. or --NR.sup.7b --, wherein each of R.sup.4b, R.sup.5b and R.sup.7b independently is hydrogen or an alkyl group having 1 to 20 carbon atoms, and R.sup.6b is hydrogen or is combined with R.sup.9b to form a benzene ring condensed with the cyclic amide ring; Z.sup.b is --CH.sub.2 --, --CR.sup.8b --, --N.dbd., .dbd.CR.sup.9b --, --CH.sub.2 --CH.sub.2 --, --NH--CH.sub.2 --, --O--CH.sub.2 --, .dbd.CH--CH.dbd., or --CO--CH.sub.2 --, wherein the right side is attached to X.sup.b, the left side is attached to Y.sup.b, R.sup.8b is hydrogen or is combined with R.sup.2b to form a benzene ring condensed with the cyclic amide ring, and R.sup.9b is hydrogen or is combined with R.sup.6b to form a benzene ring condensed with the cyclic amide ring; each of W.sup.1b and W.sup.2b independently is an atomic group that forms an acidic nucleus ring; and M.sup.b is a cation.
- 6. An oxonol compound represented by the following formula (IIa), (IIIa), (IIb), (IIIb), (IIc) or (IIIc): ##STR68## in which each of W.sup.11, W.sup.12, W.sup.21, W.sup.22, W.sup.31, W.sup.32, W.sup.41, W.sup.42, W.sup.51, W.sup.52, W.sup.61 and W.sup.62 independently is an atomic group that forms an acidic nucleus ring; each of M.sup.1, M.sup.2, M.sup.3, M.sup.4, M.sup.5 and M.sup.6 independently is a cation: each of Hc.sup.1, Hc.sup.2, Hc.sup.3 and Hc.sup.4 independently is an unsaturated heterocyclic group; and each of Ar.sup.1 and Ar.sup.2 independently is an aromatic group.
- 7. The oxonol compound as claimed in claim 6, wherein the oxonol compound is represented by the following formula (IIA), (IIIA), (IIB), (IIIB), (IIC) or (IIIC): ##STR69## in which each of X.sup.11, X.sup.12, X.sup.21, X.sup.22, X.sup.31, X.sup.32, X.sup.41, X.sup.42, X.sup.51 X.sup.52, X.sup.61 and X.sup.62 independently is --CR.sup.11 l.dbd., --CO-- or --NR.sup.12 --; each of Y.sup.11, Y.sup.12, Y.sup.21, Y.sup.22, Y.sup.31, Y.sup.32, Y.sup.41, Y.sup.42, Y.sup.51, Y.sup.52, Y.sup.61 and Y.sup.62 independently is --NR.sup.13 --, --N.dbd. or --O--; each of R.sup.11, R.sup.12 and R.sup.13 independently is an alkyl group having 1 to 6 carbon atoms, an aralkyl group having 7 to 10 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, an aryl group having 6 to 15 carbon atoms, an alkoxycarbonyl group having 2 to 6 carbon atoms, an acyl group having 2 to 6 carbon atoms, a carbamoyl group having 1 to 8 carbon atoms, a sulfamoyl group having 1 to 8 carbon atoms, a substituted amino group having 1 to 10 carbon atoms, carboxyl or a salt thereof; each of W.sup.13, W.sup.14, W.sup.23, W.sup.24, W.sup.33, W.sup.34, W.sup.43, W.sup.44, W.sup.53, W.sup.54, W.sup.63 and W.sup.64 independently is an atomic group that forms an acidic nucleus ring; each of M.sup.1 l, M.sup.21, M.sup.31, M.sup.41, M.sup.51 and M.sup.61 independently is a cation: each of Hc.sup.5, Hc.sup.6, Hc.sup.7 and Hc.sup.8 independently is an unsaturated heterocyclic group; and each of Ar.sup.3 and Ar.sup.4 independently is an aromatic group.
- 8. A light-sensitive material comprising a support, a light-sensitive layer and a non-light-sensitive layer, wherein the light-sensitive layer or the non-light-sensitive layer contains an oxonol dye represented by the following formula (I), (IIa), (IIIa), (IIb), (IIIb), (IIc) or (IIIc): ##STR70## in which Z is an atomic group that forms a cyclic amide ring; each of W.sup.1 and W.sup.2 independently is an atomic group that forms an acidic nucleus ring; and M is a cation: ##STR71## in which each of W.sup.11, W.sup.12 t W.sup.21, W.sup.22, W.sup.31, W.sup.32, W.sup.41, W.sup.42 W.sup.51, W.sup.52, W.sup.61 and W.sup.62 independently is an atomic group that forms an acidic nucleus ring; each of M.sup.1, M.sup.2, M.sup.3, M.sup.4, M.sup.5 and M.sup.6 independently is a cation: each of Hc.sup.1, Hc.sup.2, Hc.sup.3 and Hc.sup.4 independently is an unsaturated heterocyclic group; and each of Ar.sup.1 and Ar.sup.2 independently is an aromatic group.
- 9. The light-sensitive material as claimed in claim 8, wherein the non-light-sensitive layer contains the oxonol dye.
- 10. The light-sensitive material as claimed in claim 8, wherein the light-sensitive layer or the non-light-sensitive layer contains the oxonol dye in an amount of 0.5 to 1,000 mg per 1 m.sup.2 of the light-sensitive material.
- 11. The light-sensitive material as claimed in claim 8, wherein the light-sensitive layer is a silver halide emulsion layer.
- 12. A process for the synthesis of an oxonol compound, wherein an oxonol compound represented by the following formula (VI) is synthesized by a reaction of an .alpha.-ketomethylene compound represented by the following formula (IV) with a pyridinium compound represented by the following formula (V): ##STR72## in which Q is an atomic group that forms a carbon ring or a heterocyclic ring; X is a heterocyclic group; Y is a substituent group for the methine chain in the formula (VI) or the pyridinium ring in the formula (V); Z is an anion; n is an integer required for neutralizing the molecule in the formula (V); and M.sup.b is a cation.
- 13. The process for the synthesis of an oxonol compound as claimed in claim 12, wherein the pyridinium compound is represented by the following formula (Va): ##STR73## in which X is a heterocyclic group; Y is a substituent group for the pyridinium ring; Z is an anion; and n is an integer required for neutralizing the molecule.
- 14. The process for the synthesis of an oxonol compound as claimed in claim 12, wherein Y is a heterocyclic group.
- 15. The process for the synthesis of an oxonol compound as claimed in claim 14, wherein Y is a heterocyclic group represented by the following formula (Ya): ##STR74## in which A is an atomic group that forms a cyclic amide ring.
- 16. The process for the synthesis of an oxonol compound as claimed in claim 14, wherein Y is 4-pyridyl.
- 17. The process for the synthesis of an oxonol compound as claimed in claim 12, wherein X is a heterocyclic group represented by the following formula (Xa): ##STR75## in which W is an atomic group that forms a heterocyclic ring.
- 18. The light-sensitive material as claimed in claim 8, wherein each of W.sup.1 and W.sup.2 in formula (I) is independently an atomic group that forms a pyrazolone ring.
- 19. The light-sensitive material as claimed in claim 8, wherein Z in formula (I) is an atomic group that forms a five or six-membered heterocyclic ring.
- 20. The light-sensitive material as claimed in claim 8, wherein the oxonol compound is represented by the following formula (Ia): ##STR76## in which each of Z.sup.a, W.sup.1a and W.sup.2a independently is an atomic group that forms a heterocyclic ring; and M.sup.a is a cation.
- 21. The light-sensitive material as claimed in claim 8, wherein the oxonol compound is represented by the following formula (Ib): ##STR77## in which X.sup.b is --CHR.sup.1b --, --CR.sup.2b .dbd., --NR.sup.3b -- or --N.dbd., wherein R.sup.1b is hydrogen, hydroxyl or carboxyl, R.sup.2b is hydrogen or is combined with R.sup.8b to form a benzene ring condensed with the cyclic amide ring, and R.sup.3b is hydrogen or an alkyl group having 1 to 20 carbon atoms; Y is --CR.sup.4b R.sup.5b --, --CR.sup.6b .dbd. or --NR.sup.7b --, wherein each of R.sup.4b, R.sup.5b and R.sup.7b independently is hydrogen or an alkyl group having 1 to 20 carbon atoms, and R.sup.6b is hydrogen or is combined with R.sup.9b to form a benzene ring condensed with the cyclic amide ring; Z.sup.b is --CH.sub.2 --, --CR.sup.8b .dbd., --N.dbd., CR.sup.9b --, --CH.sub.2 --CH.sub.2 --, --NH--CH.sub.2 --, .dbd.CH--CH.dbd., or --CO--CH.sub.2 --, wherein the right side is attached to X.sup.b, the left side is attached to Y.sup.b, R.sup.8b is hydrogen or is combined with R.sup.2b to form a benzene ring condensed with the cyclic amide ring, and R.sup.9b is hydrogen or is combined with R.sup.6b to form a benzene ring condensed with the cyclic amide ring; each of W.sup.1b and W.sup.2b independently is an atomic group that forms an acidic nucleus ring; and M.sup.b is a cation.
- 22. The light-sensitive material as claimed in claim 8, wherein the oxonol compound is represented by
- the following formula (IIA), (IIIA), (IIB), (IIIB), (IIC) or (IIIC): ##STR78## in which each of X.sup.11, X.sup.12, X.sup.21, X.sup.22, X.sup.31, X.sup.32, X.sup.41, X.sup.42, X.sup.51, X.sup.52, X.sup.61 and X.sup.62 independently is --CR.sup.11 .dbd., --CO-- or --NR.sup.12 --; each of Y.sup.11, Y.sup.12, Y.sup.21, Y.sup.22, Y.sup.31, Y.sup.32, Y.sup.41, Y.sup.42, Y.sup.51, Y.sup.52, and Y.sup.61 independently is --NR.sup.13 --, --N.dbd. or --O--; Y.sup.62 is --NR.sup.13 -- or --N.dbd.; each of R.sup.11, R.sup.12 and R.sup.13 independently is an alkyl group having 1 to 6 carbon atoms, an aralkyl group having 7 to 10 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, an aryl group having 6 to 15 carbon atoms, an alkoxycarbonyl group having 2 to 6 carbon atoms, an acyl group having 2 to 6 carbon atoms, a carbamoyl group having 1 to 8 carbon atoms, a sulfamoyl group having 1 to 8 carbon atoms, a substituted amino group having 1 to 10 carbon atoms, carboxyl or a salt thereof; each of W.sup.13, W.sup.14, W.sup.23, W.sup.24, W.sup.33, W.sup.34, W.sup.43, W.sup.44, W.sup.53, W.sup.54, W.sup.63 and W.sup.64 independently is an atomic group that forms an acidic nucleus ring; each of M.sup.11, M.sup.21, M.sup.31, M.sup.41, M.sup.51 and M.sup.61 independently is a cation; each of Hc.sup.5, Hc.sup.6, Hc.sup.7 and Hc.sup.8 independently is an unsaturated heterocyclic group; and each of Ar.sup.3 and Ar.sup.4 independently is an aromatic group.
Priority Claims (3)
Number |
Date |
Country |
Kind |
8-206527 |
Jul 1996 |
JPX |
|
8-235893 |
Aug 1996 |
JPX |
|
9-55315 |
Mar 1997 |
JPX |
|
CROSS-REFERENCE TO RELATED APPLICATION
This is a continuation-in-part application of U.S. patent application Ser. No. 08/896,064 filed on Jul. 17, 1997, now abandoned.
Foreign Referenced Citations (1)
Number |
Date |
Country |
11119379 A2 |
Apr 1990 |
JPX |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
896064 |
Jul 1997 |
|